Pages that link to "Q34974014"
Jump to navigation
Jump to search
The following pages link to Early pregnancy azathioprine use and pregnancy outcomes (Q34974014):
Displaying 50 items.
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation (Q26765038) (← links)
- Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management (Q26777627) (← links)
- Use of thiopurines in inflammatory bowel disease (Q26824662) (← links)
- Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis (Q26827599) (← links)
- Management of inflammatory bowel disease in pregnancy (Q26865914) (← links)
- Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID) (Q26996946) (← links)
- Treatment of pregnant women with a diagnosis of inflammatory bowel disease (Q28067821) (← links)
- Managing inflammatory bowel disease in pregnancy: current perspectives (Q28068318) (← links)
- Pregnancy and Inflammatory Bowel Disease (Q28392552) (← links)
- Overcoming challenges of treating inflammatory bowel disease in pregnancy (Q30251775) (← links)
- Diagnosis and management of maternal thrombocytopenia in pregnancy (Q33401045) (← links)
- Women, kidney disease, and pregnancy (Q33410001) (← links)
- Successful twin pregnancy in a patient with ulcerative colitis using azathoprine during conception (Q33596357) (← links)
- Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient. (Q34244877) (← links)
- Gastrointestinal Conditions during Pregnancy (Q34257212) (← links)
- Review article: acute severe ulcerative colitis - evidence-based consensus statements. (Q34528270) (← links)
- Multiple sclerosis and pregnancy: maternal considerations (Q34639869) (← links)
- Surgery for Severe Ulcerative Colitis during Pregnancy: Report of Two Cases (Q35540972) (← links)
- Safety of azathioprine use during pregnancy (Q35611846) (← links)
- Autoimmune diseases and pregnancy: analysis of a series of cases. (Q35651850) (← links)
- Current opinion on treatment of inflammatory bowel disease in pregnant women (Q36524821) (← links)
- Contraceptive use in female recipients of a solid-organ transplant (Q36848191) (← links)
- Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease (Q36989959) (← links)
- Update on the Teratogenicity of Maternal Mycophenolate Mofetil (Q37093346) (← links)
- Therapy of inflammatory bowel diseases in pregnancy and lactation (Q37615417) (← links)
- Proper Use of Inflammatory Bowel Disease Drugs during Pregnancy (Q37656466) (← links)
- Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases (Q37738882) (← links)
- Inflammatory bowel disease and pregnancy: an update (Q37769252) (← links)
- Thiopurine therapy in inflammatory bowel disease (Q37798819) (← links)
- European evidenced-based consensus on reproduction in inflammatory bowel disease (Q37814564) (← links)
- Uterine transplantation: one human case followed by a decade of experimental research in animal models (Q37883428) (← links)
- Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease (Q37995572) (← links)
- Pregnancy and breastfeeding in inflammatory bowel disease (Q38050886) (← links)
- The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. (Q38069239) (← links)
- Safety considerations: breastfeeding after transplant (Q38115646) (← links)
- Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy (Q38126540) (← links)
- Inflammatory bowel disease and preterm delivery (Q38128204) (← links)
- Inflammatory bowel disease in women of reproductive age. (Q38192051) (← links)
- Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis. (Q38265958) (← links)
- High-risk pregnancy and the rheumatologist. (Q38283472) (← links)
- Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-Analysis (Q38526537) (← links)
- Use of Immunomodulators and Biologics Before, During, and After Pregnancy (Q38601306) (← links)
- Therapeutic Apheresis in Pregnancy: Three Differential Indications With Positive Maternal and Fetal Outcome (Q38895910) (← links)
- Management of pemphigus disease in pregnancy (Q39013055) (← links)
- Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment (Q39292725) (← links)
- Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease (Q39435409) (← links)
- ACG Clinical Guideline: Liver Disease and Pregnancy (Q40809932) (← links)
- Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy (Q41601749) (← links)
- Autoimmune dermatoses: impact on sexuality and fertility (Q43493031) (← links)
- Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis. (Q47141584) (← links)